Notice2023-00290
Advisory Council on Alzheimer's Research, Care, and Services; Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 10, 2023
Issuing agencies
Health and Human Services Department
Abstract
This notice announces the public meeting of the Advisory Council on Alzheimer's Research, Care, and Services (Advisory Council). The Advisory Council provides advice on how to prevent or reduce the burden of Alzheimer's disease and related dementias (ADRD) on people with the disease and their caregivers. During the meeting on January 30 and 31, 2023, the Advisory Council will hear presentations on issues related to clinical practice and plans for advanced care planning. The second day presentations will review the impact of new drug approvals and focus on risk reduction and social determinants of health. The National Institute of Neurological Disorders and Stroke (NINDS) will present research milestones from the 2022 ADRD summit and other Federal agencies will also provide updates.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 6 (Tuesday, January 10, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 6 (Tuesday, January 10, 2023)]
[Notices]
[Pages 1389-1390]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-00290]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Advisory Council on Alzheimer's Research, Care, and Services;
Meeting
AGENCY: Assistant Secretary for Planning and Evaluation, HHS.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: This notice announces the public meeting of the Advisory
Council on Alzheimer's Research, Care, and Services (Advisory Council).
The Advisory Council provides advice on how to prevent or reduce the
burden of Alzheimer's disease and related dementias (ADRD) on people
with the disease and their caregivers. During the meeting on January 30
and 31, 2023, the Advisory Council will hear presentations on issues
related to clinical practice and plans for advanced care planning. The
second day presentations will review the impact of new drug approvals
and focus on risk reduction and social determinants of health. The
National Institute of Neurological Disorders and Stroke (NINDS) will
present research milestones from the 2022 ADRD summit and other Federal
agencies will also provide updates.
DATES: The meeting will be held virtually on January 30th from 12:30
p.m. to 4:30 p.m. EST and January 31st from 12:30 p.m. to 4:30 p.m.
EST.
ADDRESSES: The meeting will be virtual. It will stream live at
<a href="http://www.hhs.gov/live">www.hhs.gov/live</a>.
Comments: Time is allocated on the agenda to hear public comments
from 4:00 p.m. to 4:30 p.m. on Tuesday January 31st. The time for oral
comments will be limited to two (2) minutes per individual. In order to
provide a public comment, please register by emailing your name to
<a href="/cdn-cgi/l/email-protection#ec828d9c8dac84849fc28b839a"><span class="__cf_email__" data-cfemail="ed838c9d8cad85859ec38a829b">[email protected]</span></a> by Thursday, January 26. Registered commenters will
receive both a dial-in number and a link to join the meeting virtually;
individuals will have the choice to either join virtually via the link,
or to call in only by using the dial-in number. Note: There may be a
30-45 second delay in the livestream video presentation of the
conference. For this reason, if you have pre-registered to submit a
public comment, it is
[[Page 1390]]
important to connect to the meeting by 3:45 p.m. to ensure that you do
not miss your name and allotted time when called. If you miss your name
and allotted time to speak, you may not be able to make your public
comment. All participant audio lines will be muted for the duration of
the meeting and only unmuted by the Host at the time of the
participant's public comment. Should you have questions during the
session email <a href="/cdn-cgi/l/email-protection#5638372637163e3e2578313920"><span class="__cf_email__" data-cfemail="58363928391830302b763f372e">[email protected]</span></a> and someone will respond to your message as
quickly as possible.
In order to ensure accuracy, please submit a written copy of oral
comments for the record by emailing <a href="/cdn-cgi/l/email-protection#7c121d0c1d3c14140f521b130a"><span class="__cf_email__" data-cfemail="d8b6b9a8b998b0b0abf6bfb7ae">[email protected]</span></a> by Wednesday, February
1, 2023. These comments will be shared on the website and reflected in
the meeting minutes.
In lieu of oral comments, formal written comments may be submitted
for the record by Wednesday, February 1, 2023 to Helen Lamont, Ph.D.,
OASPE, 200 Independence Avenue SW, Room 424E, Washington, DC 20201.
Comments may also be sent to <a href="/cdn-cgi/l/email-protection#c3ada2b3a283ababb0eda4acb5"><span class="__cf_email__" data-cfemail="630d021302230b0b104d040c15">[email protected]</span></a>. Those submitting written
comments should identify themselves and any relevant organizational
affiliations.
FOR FURTHER INFORMATION CONTACT: Helen Lamont, 202-260-6075,
<a href="/cdn-cgi/l/email-protection#7d151811181353111c101213093d15150e531a120b"><span class="__cf_email__" data-cfemail="b3dbd6dfd6dd9ddfd2dedcddc7f3dbdbc09dd4dcc5">[email protected]</span></a>. Note: The meeting will be available to the public
live at <a href="http://www.hhs.gov/live">www.hhs.gov/live</a>.
SUPPLEMENTARY INFORMATION: Notice of these meetings is given under the
Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)(1) and
(a)(2)). Topics of the Meeting: clinical care, dementia risk reduction,
social determinants of health.
Procedure and Agenda: The meeting will be webcast at <a href="http://www.hhs.gov/live">www.hhs.gov/live</a> and video recordings will be added to the National Alzheimer's
Project Act website when available, after the meeting.
Authority: 42 U.S.C. 11225; Section 2(e)(3) of the National
Alzheimer's Project Act. The panel is governed by provisions of Public
Law 92-463, as amended (5 U.S.C. Appendix 2), which sets forth
standards for the formation and use of advisory committees.
Dated: December 23, 2022.
Benjamin Sommers,
Senior Official Performing the Duties of the Assistant Secretary for
Planning and Evaluation, Deputy Assistant Secretary for Health Policy.
[FR Doc. 2023-00290 Filed 1-9-23; 8:45 am]
BILLING CODE 4150-05-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on January 10, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.